Showing 1 - 10 of 217
AFP, Published on 30/01/2026
» BEIJING - Britain's Prime Minister Keir Starmer said on Friday that the UK has a "huge amount to offer" China, after his attempts to forge closer ties prompted warnings from US President Donald Trump.
AFP, Published on 07/11/2025
» WASHINGTON - US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs.
AFP, Published on 22/08/2023
» WASHINGTON - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
AFP, Published on 05/06/2023
» WASHINGTON - A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly.
AFP, Published on 11/11/2022
» THE HAGUE - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.
AFP, Published on 12/01/2022
» Indonesia opened its coronavirus booster campaign to the public Wednesday as the country records rising infections driven by the Omicron variant.
AFP, Published on 20/12/2021
» THE HAGUE: The EU's drug regulator on Monday approved a fifth Covid jab as the US warned of a bleak winter with the Omicron variant spurring new waves of infections globally.
AFP, Published on 15/12/2021
» WASHINGTON: Pfizer said Tuesday that clinical trials confirmed its Covid pill -- a new type of treatment that should withstand the mutations seen with the Omicron variant -- drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.